$ILMN

AI Analysis

Generated on May 11, 2026

AI Score
58/ 100
Hold$ILMN

Illumina Inc.

$ILMNNASDAQHealthcareLarge-Cap

Illumina develops sequencing and array-based technologies for genetic analysis in research, clinical, and applied markets.

Market Cap
$18.0B
Revenue (TTM)
$4.5B
+3.0%
Net Income (TTM)
$0.3B
+40.0%
EPS (TTM)
$1.85
P/E Ratio
72.0
Dividend Yield
0.0%
52-Week Range
$95-$155
Beta
1.25
Dimension Scores
Fundamental
55
Technical
52
Sentiment
60
Risk / Reward
56
Momentum
58
FundTechSentRiskMome
Financial Health
Profitability
60moderate
Growth
61moderate
Liquidity
64strong
Solvency
57moderate
Efficiency
53moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $ILMN

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.